Fig. 3From: When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case reportDermatitis under treatment with mepolizumab and before starting dupilumabBack to article page